We investigated the documentation of obesity as a medical problem, and subsequent management recommendations, in patients after myocardial infarction (MI). DESIGN: We performed a cross-sectional analysis of a randomly selected sample of 627 patients discharged after an MI, from five US teaching hospitals between 1/1/01 and 12/31/02. Information was extracted from clinical notes using standardized definitions. RESULTS: Mean body mass index (BMI) was 31713 kg/m 2 , which was documented in only 14% of patients and had to be calculated post hoc in the rest. Waist circumference and waist/hip ratio were not documented at all; 83% of patients were overweight, 55% obese, and 8% morbidly obese. In only 20% of patients with BMIZ30 kg/m 2 was the diagnosis of obesity documented either as a current medical problem, as part of past medical history or as a final diagnosis. A dietary counseling was carried out in 61% of patients with BMIZ25 kg/m 2 and in 61% of patients with BMIo25 kg/m 2 , P ¼ 0.96. Weight loss was described as part of the goals/plan at discharge in 7% of overweight and 9% of obese patients. There was no change in either the level of recognition of obesity (22 vs 19%, P ¼ 0.3) or in the proportion of obese patients for whom weight loss was described as part of the goals/plan at discharge (8 vs 10%, P ¼ 0.7) before (n ¼ 301) compared to after (n ¼ 326) the Call to Action in Obesity by the Surgeon General in December 2001. CONCLUSION: Obesity is underecognized, underdiagnosed and undertreated in persons with acute MI.
Introduction
Obesity is a worldwide epidemic, the prevalence of which is steadily increasing. [1] [2] [3] [4] Excess weight is associated with higher mortality and cardiovascular events. 5, 6 The mechanisms whereby excess body fat affects the cardiovascular system include not only an indirect effect on the vascular system through risk factors like dyslipidemia, hypertension, obstructive sleep apnea, or insulin resistance, but also by an enhanced inflammatory state, a high turnover of free fatty acids with a lipotoxic effect on myocardial cells, 7 and the potential effects of high levels of leptin. 8, 9 The American Heart Association declared obesity an independent cardiovascular risk factor, 10 and the joint American Heart Association/American College of Cardiology guidelines for the management of patients with coronary disease recommend the ascertainment of body mass index (BMI), measurement of waist circumference, and weight loss for patients with BMIZ25 kg/m 2 .
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Recent data from myocardial infarction (MI) surveillance studies suggest that excess weight is the most common cardiovascular risk factor in patients with MI and that its prevalence has increased over time. 12 Nevertheless, little is known about the recognition, diagnosis, and management of obesity in those at high risk for cardiovascular death, such as patients with MI. As the identification and recognition of a medical problem is usually the first step to design potentially effective strategies for management and prevention, we investigated the documentation of obesity as a medical problem, the recording of basic anthropometric measurements, and obesity-related management recommendations in hospitalized patients with acute MI. We also compared the documentation and management of obesity before and after the Call to Action in Obesity by the Surgeon General in December 2001. Hypertension was defined as having a documented diagnosis in the admission note as part of the past medical history, or if described as 'hypertensive patient'. Patients taking medications with antihypertensive properties or patients with elevated blood pressure values during hospitalization were not considered as having hypertension unless the diagnosis was documented in the chart. Diabetes was defined as having a documented diagnosis of diabetes mellitus, or using insulin or oral hypoglycemic drugs. Patients with elevated serum glucose levels, without documented diagnosis of diabetes or use of diabetes medications, were not considered to have diabetes mellitus. Hyperlipidemia was defined as having one or more of a documented diagnosis in the clinical chart, using a lipid-lowering agent, LDL cholesterol greater than 160 mg/dl or total cholesterol higher than 220 mg/dl. Family history of coronary artery disease was defined as having a first degree male relative o55 y of age or female o65 y of age with history of CABG, MI, angina, or angioplasty. Dietary counseling was defined as having a clinical note by a dietician, a nutritional report, or statement in the physician's notes that the patient was evaluated by a dietician or nutritionist. Admission note was defined as the first note in the coronary unit, intensive care unit, or telemetry unit. If several notes were available (attending physician, senior resident, fellow, medical student), we used all the information available from all of them. Brief notes from the emergency department were not used unless no other admission notes were available. Progress notes were defined as notes by staff physicians, fellows, residents, or medical students. Discharge summary, if not specified as such, was defined as the last note in the chart. Final notes had priority over preliminary notes. Data were collected and entered in the computer in a single center. Extreme values (outliers) were either confirmed or corrected by reviewing the original source of information. Data extractors were experienced in chart review and knowledgeable in cardiovascular diseases. Reproducibility of data was tested by comparing values from 38 patients from all participant hospitals, for whom data was extracted twice by the same investigator at least 2 weeks apart.
Statistical analysis
Patients with missing body weight or height were not included in the analysis. Data are described as percentages, or mean values7standard deviation. Differences in proportions were tested using the Mantel-Haenszel w 2 and the exact , P ¼ 0.96. Weight control or weight loss was described as part of the goals/plan at discharge in 7% of overweight and 9% of obese patients ( Table 2) .
Discussion
Obesity is a major cardiovascular risk factor with a high and rising prevalence. Our study shows that obesity is nevertheless rarely documented as a diagnosis or medical problem in patients with MI. BMI was only calculated in a small percentage of patients. The percentage of patients receiving dietary counseling was the same among obese and nonobese patients, suggesting that factor other than obesity influence the decision to order a dietary evaluation in patients with MI. Furthermore, these data also suggest that obesity may be profoundly undertreated, as weight loss was described as part of the goals or plan at the time of discharge in only a small minority (9%) of patients with obesity.
These findings suggest an alarming low level of awareness and sensitivity to obesity as a medical problem among Obesity awareness after myocardial infarction F Lopez-Jimenez et al physicians taking care of patients with MI, despite the following: (1) the powerful and independent contribution of obesity to cardiovascular risk; (2) the high risk cardiovascular status of post-MI patients; and (3) the current and increasing efforts to improve the identification and treatment of obesity by medical organizations, scientific journals, and both lay and governmental agencies. [14] [15] [16] [17] [18] Our findings may actually underestimate the magnitude of the problem because they included data only from teaching hospitals, where compliance with guidelines and scientific evidence may arguably be expected to be higher than in other clinical settings. The low awareness of obesity among physicians taking care of patients with MI has several potential explanations. First, obesity was not formally considered a disease until the World Health Organization and the International Classification of Diseases officially declared obesity to be a morbid condition. 19 Until recently, Medicare, Medicaid and major health insurance companies did not officially considered obesity as a disease and do not generally reimburse for obesity treatment, unless related comorbidities exist. 20, 21 Also, before strong evidence from large prospective studies controlling for several potential confounders showed a solid and independent association between obesity and cardiovascular disease, there was major controversy on whether or not obesity was related to atherosclerosis. 22, 23 Moreover, the
Framingham risk score, one of the most widely used methods for estimating cardiovascular risk, does not include obesity in the equation. 24 Finally, because the treatment of obesity is difficult, obesity may escape the attention of physicians who may be more inclined to focus on the treatment of risk factors for which the likelihood of success is higher. 25, 26 Except for bariatric surgery, most of the weight loss strategies have failed to prove effectiveness to induce significant and sustained weight loss in the long term. Also, the treatment of obesity is rarely reimbursed despite the substantial amount of resources that are needed in the implementation of a comprehensive weight loss program. This lack of effectiveness and financial incentives make the management of obesity less attractive, particularly if the other risk factors associated with obesity are under control. Our study also shows that the Call to Action in Obesity by the Surgeon General in December 2001 had no discernible short-term effect on the recognition and treatment of obesity in patients with MI. There was no change before and after 13 December 2001, either in the level of recognition of obesity or in the proportion of obese patients for whom weight loss was described as part of the goals/plan at discharge. This is evident despite widespread coverage by mass media that disseminated the Call to Action not only among health care providers but also to the general public. To the best of our knowledge, our study assessed for first time the impact of a national recommendation issued by the Surgeon General on physicians' behavior. Previous studies in patients with MI have shown only a slow change in physician behavior in response to scientific publications. 27 
Strengths and limitations
This study included MI patients from several US geographic regions and had a representation of minorities close to the US ethnic distribution. 28 Also, one-third of the patients were women. This was due, in part, to sampling consecutive patients and limiting the exclusion criteria to a minimum. By doing so, we hopefully minimized participation and selection bias. The use of standardized definitions sought to minimize any variability in the manner in which risk factors, weight and other clinical data were documented. Also, prespecified aims increase the scientific validity of the study by avoiding testing of post hoc hypotheses. Despite the use of standardized definitions, the retrospective nature of this study has implicit limitations. It is possible that the ascertainment of obesity in the clinical notes could have been underestimated by overlooking the diagnosis of obesity, particularly when reviewing extensive clinical information. Furthermore, we use the documentation of obesity in the clinical chart by the healthcare provider as a proxy for the recognition and awareness of obesity as a medical problem. Also, advice regarding obesity and its management may have been provided but not documented. Hence, the recognition and management of obesity in these patients might be underestimated. Additionally, this study included only patients who had survived the MI and may therefore introduce survival bias. Finally, our data cannot exclude the possibilities that obese or overweight patients were enrolled in weight management programs after discharge or that the physicians providing their outpatient care indeed considered obesity as a medical problem and had weight management as part of their treatment goals.
In conclusion, despite its classification as a major cardiovascular risk factor, its high and rising prevalence, and being the subject of recommendations by medical organizations and government agencies, obesity is still under-recognized, under-diagnosed, and under-treated in patients at high risk for cardiovascular death, such as in patients after MI. Further efforts are required to increase the awareness of the importance of documenting and treating obesity among physicians, particularly those taking care of patients with cardiovascular disease.
